CA2785136C - Construction de fibres de collagene pour le remplacement de ligaments croises - Google Patents
Construction de fibres de collagene pour le remplacement de ligaments croises Download PDFInfo
- Publication number
- CA2785136C CA2785136C CA2785136A CA2785136A CA2785136C CA 2785136 C CA2785136 C CA 2785136C CA 2785136 A CA2785136 A CA 2785136A CA 2785136 A CA2785136 A CA 2785136A CA 2785136 C CA2785136 C CA 2785136C
- Authority
- CA
- Canada
- Prior art keywords
- collagen
- construct
- cruciate ligament
- fibers
- fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 505
- 108010035532 Collagen Proteins 0.000 title claims abstract description 505
- 229920001436 collagen Polymers 0.000 title claims abstract description 505
- 239000000835 fiber Substances 0.000 title claims abstract description 389
- 210000003041 ligament Anatomy 0.000 title claims description 170
- 238000000034 method Methods 0.000 claims abstract description 74
- 238000004519 manufacturing process Methods 0.000 claims abstract description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 241001417092 Macrouridae Species 0.000 claims abstract description 19
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 claims abstract description 19
- 241000124008 Mammalia Species 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims description 38
- 210000002435 tendon Anatomy 0.000 claims description 29
- 238000004659 sterilization and disinfection Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 15
- 210000001264 anterior cruciate ligament Anatomy 0.000 claims description 11
- 201000010099 disease Diseases 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 230000000399 orthopedic effect Effects 0.000 claims description 11
- 238000002955 isolation Methods 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 8
- 208000027418 Wounds and injury Diseases 0.000 claims description 7
- 208000014674 injury Diseases 0.000 claims description 7
- 230000005855 radiation Effects 0.000 claims description 7
- 210000003127 knee Anatomy 0.000 claims description 6
- 210000000513 rotator cuff Anatomy 0.000 claims description 6
- 210000004439 collateral ligament Anatomy 0.000 claims description 5
- 230000007850 degeneration Effects 0.000 claims description 5
- 210000002967 posterior cruciate ligament Anatomy 0.000 claims description 5
- 206010065433 Ligament rupture Diseases 0.000 claims description 4
- 210000003423 ankle Anatomy 0.000 claims description 3
- 206010043248 Tendon rupture Diseases 0.000 claims description 2
- 210000000426 patellar ligament Anatomy 0.000 claims description 2
- 238000009940 knitting Methods 0.000 description 51
- 239000007943 implant Substances 0.000 description 46
- 239000000243 solution Substances 0.000 description 33
- 210000001519 tissue Anatomy 0.000 description 29
- 238000002513 implantation Methods 0.000 description 26
- 241001465754 Metazoa Species 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 20
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 16
- 239000002953 phosphate buffered saline Substances 0.000 description 16
- 238000004873 anchoring Methods 0.000 description 13
- 210000002950 fibroblast Anatomy 0.000 description 12
- 241000282412 Homo Species 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000009954 braiding Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 244000309715 mini pig Species 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 9
- 238000001727 in vivo Methods 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000003102 growth factor Substances 0.000 description 7
- 230000035755 proliferation Effects 0.000 description 7
- 210000003813 thumb Anatomy 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000004804 winding Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 5
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 5
- 210000001361 achilles tendon Anatomy 0.000 description 5
- 230000000735 allogeneic effect Effects 0.000 description 5
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- 102000019034 Chemokines Human genes 0.000 description 4
- 108010012236 Chemokines Proteins 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
- 102000016359 Fibronectins Human genes 0.000 description 4
- 108010067306 Fibronectins Proteins 0.000 description 4
- 108010009583 Transforming Growth Factors Proteins 0.000 description 4
- 102000009618 Transforming Growth Factors Human genes 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 230000035605 chemotaxis Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940126864 fibroblast growth factor Drugs 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- 108010081589 Becaplermin Proteins 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 3
- 241000283086 Equidae Species 0.000 description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- ODYCAZSSUVCHNU-XLAORIBOSA-N Laurencin Natural products CC[C@H]1C[C@H](CC=CC[C@@H]1Br)[C@@H](CC=CC#C)OC(=O)C ODYCAZSSUVCHNU-XLAORIBOSA-N 0.000 description 3
- 241000906034 Orthops Species 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000012292 cell migration Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 230000000921 morphogenic effect Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 239000012209 synthetic fiber Substances 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 2
- 241000289619 Macropodidae Species 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 229920006328 Styrofoam Polymers 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000009945 crocheting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 210000002310 elbow joint Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 208000030175 lameness Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 108010000685 platelet-derived growth factor AB Proteins 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- JTIGKVIOEQASGT-UHFFFAOYSA-N proquazone Chemical compound N=1C(=O)N(C(C)C)C2=CC(C)=CC=C2C=1C1=CC=CC=C1 JTIGKVIOEQASGT-UHFFFAOYSA-N 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000008261 styrofoam Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 241000981770 Buddleja asiatica Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000031586 Elymus elymoides Species 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010090250 Growth Differentiation Factor 6 Proteins 0.000 description 1
- 101710204281 Growth/differentiation factor 6 Proteins 0.000 description 1
- 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
- 101710204283 Growth/differentiation factor 7 Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 241000289581 Macropus sp. Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/081—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2913—Rod, strand, filament or fiber
- Y10T428/2915—Rod, strand, filament or fiber including textile, cloth or fabric
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/40—Knit fabric [i.e., knit strand or strip material]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
La présente invention concerne une construction de fibres de collagène à partir de fibres individuelles de collagène, qui est stérilisée avec de l'alcool et par irradiation et n'est pas occupée par des cellules, les fibres individuelles de collagène étant isolées de tissus contenant du collagène à partir de mammifères. La présente invention concerne un procédé de fabrication d'une construction de fibres de collagène à partir de fibres individuelles de collagène, qui est stérilisée avec de l'alcool et par irradiation et n'est pas occupée par des cellules, les fibres individuelles de collagène étant isolées de tissus contenant du collagène à partir de queues de rats. L'invention décrit enfin l'utilisation de constructions de fibres de collagène comme xéno-implant.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009059901A DE102009059901A1 (de) | 2009-12-21 | 2009-12-21 | Kollagenfaserkonstrukte für den Kreuzbandersatz |
| DE102009059901.0 | 2009-12-21 | ||
| PCT/EP2010/070312 WO2011085920A1 (fr) | 2009-12-21 | 2010-12-20 | Construction de fibres de collagène pour le remplacement de ligaments croisés |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2785136A1 CA2785136A1 (fr) | 2011-07-21 |
| CA2785136C true CA2785136C (fr) | 2018-12-11 |
Family
ID=43927951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2785136A Active CA2785136C (fr) | 2009-12-21 | 2010-12-20 | Construction de fibres de collagene pour le remplacement de ligaments croises |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130018463A1 (fr) |
| EP (1) | EP2515797A1 (fr) |
| CA (1) | CA2785136C (fr) |
| DE (1) | DE102009059901A1 (fr) |
| WO (1) | WO2011085920A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3185918B1 (fr) * | 2014-08-28 | 2021-08-18 | MiMedx Group, Inc. | Greffe de tissu renforcée par collagène |
| CA3016171C (fr) * | 2016-03-02 | 2024-02-20 | The Regents Of The University Of Michigan | Greffon de tendon modifie pour reparation de coiffe des rotateurs |
| CN105671723A (zh) * | 2016-04-07 | 2016-06-15 | 张立文 | 一种以胶原纤维为主作为皮层的包芯纱及其加工方法 |
| US20200205963A1 (en) * | 2018-10-08 | 2020-07-02 | Kambiz Behzadi | Connective tissue grafting |
| EP4125995A4 (fr) * | 2020-03-31 | 2024-04-10 | 3-D Matrix, Ltd. | Stérilisation de peptides à auto-assemblage par irradiation |
| JP2024113667A (ja) * | 2023-02-09 | 2024-08-22 | エンボディ，インコーポレイテッド | 編組された外科用インプラント |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078744A (en) * | 1987-09-04 | 1992-01-07 | Bio-Products, Inc. | Method of using tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers |
| FR2641289B1 (fr) * | 1989-01-04 | 1991-03-15 | Mitz Vladimir | Procede d'obtention de fibres de collagene de peau d'origine humaine, fibres ainsi obtenues et composition les contenant |
| US5171273A (en) * | 1989-01-13 | 1992-12-15 | University Of Medicine And Dentistry Of New Jersey | Synthetic collagen orthopaedic structures such as grafts, tendons and other structures |
| DE10026789B4 (de) * | 2000-05-31 | 2004-09-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Knorpelersatz und Verfahren zu dessen Herstellung |
| US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
| US20030003157A1 (en) * | 2001-06-06 | 2003-01-02 | University Of Medicine & Dentistry Of New Jersey | Collagen compositions and methods for making and using the same |
| DE102006026591B4 (de) * | 2006-05-31 | 2008-09-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Isolierung von Kollagen aus kollagenhaltigem Gewebe |
| US20080108681A1 (en) * | 2006-10-27 | 2008-05-08 | Access Business Group International Llc | Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions |
| CA2674470C (fr) * | 2006-12-27 | 2016-05-10 | Shriners Hospitals For Children | Implants de fibres tissees et/ou tressees et leurs procedes de fabrication |
| US20080260794A1 (en) * | 2007-02-12 | 2008-10-23 | Lauritzen Nels J | Collagen products and methods for producing collagen products |
| CA2682701A1 (fr) * | 2007-03-20 | 2008-09-25 | Serica Technologies, Inc. | Dispositif prothetique et procede de fabrication de celui-ci |
| US8133268B2 (en) * | 2007-05-30 | 2012-03-13 | Cordis Corporation | Stent/fiber structural combinations |
| WO2009139871A2 (fr) * | 2008-05-16 | 2009-11-19 | Mimedx, Inc. | Constructions médicales de longueurs torsadées de fibres de collagène et leurs procédés de fabrication |
| WO2010000951A1 (fr) | 2008-07-01 | 2010-01-07 | Vygi | Systeme d'ouverture/fermeture assistee d'un couvercle et conteneur a dechets muni d'un tel couvercle |
| AU2009273766A1 (en) * | 2008-07-24 | 2010-01-28 | The University Of Western Australia | A collagen scaffold for cell growth and a method for producing same |
| US20120029655A1 (en) * | 2009-04-08 | 2012-02-02 | International Centre For Cardio Thoracic And Vascular Diseases | Implantable xenograft prepared from a non-human tissue portion |
-
2009
- 2009-12-21 DE DE102009059901A patent/DE102009059901A1/de not_active Ceased
-
2010
- 2010-12-20 EP EP10795706A patent/EP2515797A1/fr not_active Withdrawn
- 2010-12-20 US US13/517,248 patent/US20130018463A1/en not_active Abandoned
- 2010-12-20 CA CA2785136A patent/CA2785136C/fr active Active
- 2010-12-20 WO PCT/EP2010/070312 patent/WO2011085920A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| US20130018463A1 (en) | 2013-01-17 |
| DE102009059901A1 (de) | 2011-06-22 |
| WO2011085920A1 (fr) | 2011-07-21 |
| EP2515797A1 (fr) | 2012-10-31 |
| CA2785136A1 (fr) | 2011-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5615891B2 (ja) | 腱の人工装具およびその製造方法 | |
| US8177839B2 (en) | Woven and/or braided fiber implants and methods of making same | |
| EP0955949B1 (fr) | Amelioration de la resistance de structures a base de collagene | |
| CA2785136C (fr) | Construction de fibres de collagene pour le remplacement de ligaments croises | |
| AU760957B2 (en) | Implants for connective tissue reconstruction | |
| EP3228279B1 (fr) | Procédé de fabrication de greffe de tissu mou renforcé avec construction de boucle/aiguille de suture | |
| Farnebo et al. | Reconstruction of the Tendon–Bone Insertion With Decellularized Tendon–Bone Composite Grafts: Comparison With Conventional Repair | |
| Simon et al. | Tissue Engineered Anterior Cruciate Ligament Graft | |
| CA2260153C (fr) | Amelioration de la resistance de structures a base de collagene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151218 |